Explaining a first-generation antipsychotic and EPS risks (CASC)

Station instructions (candidate)

You have 7 minutes. Explain why a first-generation antipsychotic is being considered after metabolic harm on olanzapine, what major trials say about effectiveness and quality of life versus “newer” drugs, what movement side effects to watch for (stiffness, restlessness, rare lock-jaw emergency), how low modern dosing and monitoring reduce risk, and that long-term abnormal movements are more common with older drugs but can occur with newer ones too. Offer choice, written information, and a clear safety net. Do not coerce depot. Do not guarantee zero side effects. Do not dismiss his fears.^[1][2][3]